Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anais Prats"'
In vitro and in vivo characterization of an interleukin-15 antagonist peptide by metabolic stability
Autor:
Yunier, Rodríguez-Álvarez, Ania, Cabrales-Rico, Alejandro, Perera-Pintado, Anais, Prats-Capote, Hilda E, Garay-Pérez, Osvaldo, Reyes-Acosta, Erik, Pérez-García, Araceli, Chico-Capote, Alicia, Santos-Savio
Publikováno v:
Journal of peptide science : an official publication of the European Peptide Society. 24(4-5)
Interleukin (IL)-15 is an inflammatory cytokine that constitutes a validated therapeutic target in some immunopathologies, including rheumatoid arthritis (RA). Previously, we identified an IL-15 antagonist peptide named [K6T]P8, with potential therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::04807d46ff185c8e8d990deb7d09b445
https://pubmed.ncbi.nlm.nih.gov/29656472
https://pubmed.ncbi.nlm.nih.gov/29656472
Immunoscintigraphy with 99mTc-14F7 and 99mTc-Nimotuzumab in patients with non-small cell lung cancer
Publikováno v:
Trends in Cancer Research and Chemotherapy. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33f542f638d96640e693535999f8f505
https://doi.org/10.15761/tcrc.1000112
https://doi.org/10.15761/tcrc.1000112
Publikováno v:
Clinical nuclear medicine. 41(3)
Detection of bone metastases indicates poor prognosis for patients with prostate cancer. The immunotherapy with monoclonal antibody has been an important advance in the treatment of the cancer in the last years. Nimotuzumab is a humanized IgG1 monocl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fef4ffa31c37b83d917a5943e46d011
https://pubmed.ncbi.nlm.nih.gov/26447381
https://pubmed.ncbi.nlm.nih.gov/26447381
Publikováno v:
Nucleus, Vol 0, Iss 67 (2020)
In the beginning, radionuclide-labeled monoclonal antibodies were widely employed for the study of various diseases, mainly oncological, by immunoscintigraphy. They were gradually replaced by molecules with better performance such as peptides and 18F
Externí odkaz:
https://doaj.org/article/6bbc562c3b6b426ba7fbdd046efc0da2
Autor:
Alejandro Perera Pintado, Leonel A. Torres Aroche, Alex Vergara Gil, Juan F. Batista Cuéllar, Anaís Prats Capote
Publikováno v:
Nucleus, Vol 0, Iss 62, Pp 2-9 (2017)
SPECT/CT has represented not only the possibility of acquiring anatomical and functional images in one single study, but also a revolution for the clinical management of several diseases, taking the better of each one of these imaging modalities. The
Externí odkaz:
https://doaj.org/article/a4d4a45cb7b84891998ddb0af684d070
Autor:
Anaís Prats-Capote, Alejandro Perera-Pintado, Raúl Mocelo-Castell, Yoel Griffith-Pérez, Marisé García-Batlle, Beatriz O´Reilly-Dueñas, Osmar Calderón-Sánchez, Rafaela Pérez-Perera, Chryslaine Rodríguez-Tanty
Publikováno v:
Revista CENIC Ciencias Químicas, Vol 47, Iss 1, Pp 34-42 (2016)
La aparición de metástasis óseas constituye la complicación más frecuente en las enfermedades oncológicas. Éstas son usualmente incurables, producen severos dolores, disminuyendo las expectativas y la calidad de vida de los pacientes. El uso d
Externí odkaz:
https://doaj.org/article/2cd788a1932749599781d20e90145109
Autor:
Marquiza Sablón-Carrazana, Isaac Fernández, Alberto Bencomo, Reyna Lara-Martínez, Suchitil Rivera-Marrero, Guadalupe Domínguez, Rafaela Pérez-Perera, Luis Felipe Jiménez-García, Nelly F Altamirano-Bustamante, Massiel Diaz-Delgado, Fernand Vedrenne, Lina Rivillas-Acevedo, Karina Pasten-Hidalgo, María de Lourdes Segura-Valdez, Sergio Islas-Andrade, Eulalia Garrido-Magaña, Alejandro Perera-Pintado, Anaís Prats-Capote, Chryslaine Rodríguez-Tanty, Myriam M Altamirano-Bustamante
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0135292 (2015)
The increasing prevalence of conformational diseases, including Alzheimer's disease, type 2 Diabetes Mellitus and Cancer, poses a global challenge at many different levels. It has devastating effects on the sufferers as well as a tremendous economic
Externí odkaz:
https://doaj.org/article/1344ee3767f543d39982f94d11ff7837